Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Osteopore Ltd. ( (AU:OSX) ) just unveiled an announcement.
Osteopore has entered a partnership with the Tam Shiu Anatomical Modelling Laboratory at the University of Hong Kong to advance digital design and workflows for anatomical models, surgical guides, cutting jigs and the digital reconstruction of bone gaps and augmentation sites across the body. As part of the collaboration, the company will establish its second Global Centre of Excellence in Hong Kong — its first outside Singapore — a move aimed at deepening engagement with surgeons, integrating more closely with the hospital ecosystem, and strengthening its operational and clinical footprint in a key Asian medical hub.
The most recent analyst rating on (AU:OSX) stock is a Hold with a A$0.02 price target. To see the full list of analyst forecasts on Osteopore Ltd. stock, see the AU:OSX Stock Forecast page.
More about Osteopore Ltd.
Osteopore Limited is an Australian-Singaporean regenerative medicine company and a global leader in 3D‑printed biomimetic and bioresorbable implants, focusing on custom implantable devices that support bone reconstruction and augmentation in collaboration with surgeons and hospital systems.
Average Trading Volume: 18,254,746
Technical Sentiment Signal: Sell
Current Market Cap: A$5.44M
See more insights into OSX stock on TipRanks’ Stock Analysis page.